Health
An existing drug may function as targeted therapy for ALL in children – News-Medical.Net
A new study from Linköping University has shown that the tumour-inhibiting gene TET2 is silenced in a large fraction of cases…

A new study from Linköping University has shown that the tumor-inhibiting gene TET2 is silenced in a large fraction of cases of acute lymphoblastic leukemia (ALL) in children. The scientists show that the gene can be reactivated by treatment with an existing…
Continue Reading
-
Business23 hours ago
Why is Alphabet stock worth less than Nvidia, Microsoft, Apple, and Amazon even though it is the most profitable S&P 500 company?
-
Noosa News22 hours ago
‘Sunny, benign’ school holiday weather after morning showers in parts of Queensland
-
General17 hours ago
Developer warns wind energy capacity may not be ready by WA coal deadline
-
General22 hours ago
Older Aussies back increased superannuation tax